Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 First in Human, Time Lagged, Parallel-Group, Single Ascending Dose Study of Tyzivumab in Healthy Adult Volunteers

NCT03443830 is registered in ClinicalTrials.gov with Tychan Pte Ltd. as lead sponsor.

NCT NCT03443830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03443830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 First in Human, Time Lagged, Parallel-Group, Single Ascending Dose Study of Tyzivumab in Healthy Adult Volunteers
Lead sponsor
Tychan Pte Ltd.
Phase
Phase 1
Overall status
Completed
Start date
February 8, 2018
Completion date
December 4, 2018
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment of acute zika virus infection